Subdomains of Post-COVID Syndrome (PCS) – a population-based study
The two newly defined PCS scores may enable a more refined assessment of PCS severity, both in a research context and to delineate distinct PCS subdomains with possibly different therapeutic and interventional needs in clinical practise.
Authors
- Derk Frank (ORCID: https://orcid.org/0000-0001-7561-075X)
- Thalea Tamminga
- Lena Schmidbauer (ORCID: https://orcid.org/0000-0003-2606-8655)
- Karl Georg Hæusler (ORCID: https://orcid.org/0000-0002-6389-5054)
- Thomas Bahmer (ORCID: https://orcid.org/0000-0002-7677-7057)
- Olga Miljukov (ORCID: https://orcid.org/0000-0003-4790-5918)
- Carolin Nürnberger (ORCID: https://orcid.org/0009-0007-1029-3707)
- Wolfgang Lieb (ORCID: https://orcid.org/0000-0003-2544-4460)
- Julia Fricke (ORCID: https://orcid.org/0000-0002-7625-474X)
- Peter U. Heuschmann (ORCID: https://orcid.org/0000-0002-2681-3515)
- Klaus F. Rabe (ORCID: https://orcid.org/0000-0002-7020-1401)
- Irina Chaplinskaya-Sobol (ORCID: https://orcid.org/0000-0003-4811-1028)
- Anne-Kathrin Ruß (ORCID: https://orcid.org/0000-0002-4593-8698)
- Jörg Janne Vehreschild (ORCID: https://orcid.org/0000-0002-5446-7170)
- Jan Heyckendorf (ORCID: https://orcid.org/0000-0003-4203-8421)
- Martin Witzenrath (ORCID: https://orcid.org/0000-0002-9787-5633)
- Michael Krawczak (ORCID: https://orcid.org/0000-0003-2603-1502)
- Corina Maetzler
- Walter Maetzler (ORCID: https://orcid.org/0000-0002-5945-4694)
- Jens‐Peter Reese (ORCID: https://orcid.org/0000-0003-3545-2552)
- Stefan Schreiber (ORCID: https://orcid.org/0000-0003-2254-7771)
- Katharina S. Appel (ORCID: https://orcid.org/0000-0002-3760-6992)
- Thomas Keil (ORCID: https://orcid.org/0000-0002-9108-3360)
- Andrea Schäfer
- Martin Laudien (ORCID: https://orcid.org/0000-0003-3342-3336)
- Lilian Krist (ORCID: https://orcid.org/0000-0002-6089-5163)
- Stefan Störk (ORCID: https://orcid.org/0000-0002-1771-7249)
- Caroline Morbach (ORCID: https://orcid.org/0000-0002-0920-6094)
- Carmen Scheibenbogen (ORCID: https://orcid.org/0000-0002-8554-9638)
- Nour Eddine El Mokhtari
- Sabrina Ballhausen-Lübcker
Institutions
- Goethe University Frankfurt (DE)
- University of Würzburg (DE)
- Frankfurt Institute for Advanced Studies (DE)
- Health and Safety Authority (IE)
- University Hospital Schleswig-Holstein (DE)
- German Center for Infection Research (DE)
- Universitätsklinikum Würzburg (DE)
- German Center for Lung Research (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- LungenClinic Grosshansdorf (DE)
- University Hospital Ulm (DE)
- Institut für Berufliche Aus- und Fortbildung (DE)
- University of Göttingen (DE)
- Charité - Universitätsmedizin Berlin (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1186/s12879-025-11368-6
- Citations
- 2
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- Amgen
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Biogen
- Alnylam Pharmaceuticals
- Celgene
- Chiesi Farmaceutici
- Boston Scientific Corporation
- European Respiratory Society
- Deutsches Zentrum für Infektionsforschung
- Regeneron Pharmaceuticals
- Mylan
- International Max Planck Research School for Environmental, Cellular and Molecular Microbiology
- Celltrion
- Insmed
- European Commission
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Daiichi-Sankyo
- Novo Nordisk
- NordForsk
- Astellas Pharma
- Shionogi
- Deutsche Herzstiftung
- Deutsche Krebshilfe
- Vifor Pharma
- Deutsches Zentrum für Lungenforschung
- Servier
- Sun Pharma
- Gemeinsame Bundesausschuss
- Daiichi Sankyo Europe